In this Breastcancer.org podcast, Brian Wojciechowski, M.D., Breastcancer.org’s medical adviser, discusses Ibrance, a medicine that was approved to treat metastatic, hormone-receptor-positive breast cancer in February 2015. Listen to the podcast to hear Dr. Wojciechowski explain:

how Ibrance works

who is eligible to take Ibrance

how Ibrance is taken and whether any other medicines are taken with it

the side effects that Ibrance can cause